Loading...
Loading...
India's rivaroxaban imports from OMAN total $708 across 11 shipments from 1 foreign suppliers. OMAN PHARMACEUTICAL PRODUCTS CO. LLC leads with $708 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include AET LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for rivaroxaban โ a concentrated sourcing relationship with select suppliers from OMAN.

OMAN PHARMACEUTICAL PRODUCTS CO. LLC is the leading Rivaroxaban supplier from OMAN to India, with import value of $708 across 11 shipments. The top 5 suppliers โ OMAN PHARMACEUTICAL PRODUCTS CO. LLC โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | OMAN PHARMACEUTICAL PRODUCTS CO. LLC | $708 | 11 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AET LABORATORIES PRIVATE LIMITED | $708 | 11 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Rivaroxaban suppliers from OMAN to India include OMAN PHARMACEUTICAL PRODUCTS CO. LLC. The leading supplier is OMAN PHARMACEUTICAL PRODUCTS CO. LLC with import value of $708 USD across 11 shipments. India imported Rivaroxaban worth $708 USD from OMAN in total across 11 shipments.
India imported Rivaroxaban worth $708 USD from OMAN across 11 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Rivaroxaban sourced from OMAN include AET LABORATORIES PRIVATE LIMITED. The largest buyer is AET LABORATORIES PRIVATE LIMITED with $708 in imports across 11 shipments.
The total value of Rivaroxaban imports from OMAN to India is $708 USD, across 11 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists